Theranica

How can we better support veterans living with migraine, especially when they often face multiple coexisting conditions? The VA, the largest healthcare system in the U.S., serves veterans with complex, multifaceted health concerns. Many veterans with migraine also contend with coexisting conditions such as mental health, sleep disorders, and non-headache pain.[1] Integrating the Nerivio? REN wearable into migraine treatment plans allows healthcare professionals a way to provide a safe, effective, and drug-free option to veterans. This non-drug therapy is less likely to interact with other medications that veterans may be taking to address other conditions. We’re proud to support veterans in managing their migraine disease. The Nerivio REN wearable, covered under VA benefits, empowers veterans to manage their migraine symptoms without relying solely on medication. Learn more about how to incorporate Nerivio into your care plan: https://lnkd.in/gS_fFSNJ —-------------------------------------------------- 1. Seng et al. “Frequency, Demographics, Comorbidities, and Health Care Utilization by Veterans With Migraine”. 2022.

What if diagnosing migraine early could pave the way for long-term relief in children? Early diagnosis and proactive treatment can make all the difference for young people living with migraine and can help set the course for their future well-being.[1] Brad Torphy, M.D., Managing Director of the Chicago Headache Center and Research Institute, shares insights on the importance of early intervention for children living with migraine. We’re proud to uniquely support these efforts with the Nerivio? REN wearable—the first FDA-cleared, drug-free option for both acute and preventive migraine treatment for children 8 and older. With Nerivio, young patients can manage their migraine symptoms safely, independently, and confidently as they grow. Learn more here: nerivio.com —------------------------------------------------------ 1. Hershey et al. “Patterns, Barriers, and Preferences of Treating Migraine Within the School Setting: A Survey Study of Students”. 2024.

Two events. One mission: redefining migraine care for patients. This week, we're proud to be a part of migraine conversations at 2 events: The Headache Cooperative of New England and the Association of VA Neurologists Meeting. There is a pressing need to rethink migraine management for patient populations that have unique needs, like veterans and patients with comorbidities. The FDA-cleared Nerivio? REN wearable provides a safe, non-drug approach for acute and preventive migraine treatment for ages 8 and above. We look forward to learning from leading providers and being part of the conversation on advancing migraine care. Learn more about how the REN wearable is transforming migraine care here: nerivio.com

Pediatric migraine: A quality of life issue that demands attention. A study analyzed 572 children aged 5-18 at a specialized headache clinic and found that their quality of life was significantly reduced—on par with children living with juvenile rheumatoid arthritis or cancer.[1] This striking finding emphasizes the urgent need for effective treatments for children and adolescents struggling with migraine. The Nerivio? REN wearable offers a promising intervention. As the first and only FDA-cleared, non-drug treatment for children ages 8 and up, it works by stimulating the body’s pain inhibition mechanism. This safe and effective option can help children and adolescents regain control of their migraine so that it doesn't impact their school performance, emotional health, and social lives.[2] Healthcare providers, it’s time to rethink first-line migraine interventions. By integrating targeted treatments like the REN wearable, you can make a significant difference in the lives of young patients. Learn more here: https://lnkd.in/gX6pb6eR —----------------------------------------------- 1. Powers et al. “Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses". 2003. 2. Hershey et al. “Patterns, Barriers, and Preferences of Treating Migraine Within the School Setting: A Survey Study of Students”. 2024.

What if your voice could make migraine relief more accessible for the patients who need it most? Healthcare providers have the power to advocate for affordable, accessible care. Migraine isn’t just a headache. It’s a debilitating neurological disorder impacting approximately 14.7% of the U.S. population.[1] This is where the Nerivio? REN wearable makes the difference. As an FDA-cleared, non-drug treatment for both preventive and acute migraine care, it empowers individuals to take control of their migraine. Yet, despite its benefits, the Nerivio REN wearable isn’t widely covered by insurance, placing a financial strain on families that can delay access to safe and effective migraine relief. Advocacy is essential to driving further expansion of coverage. For more information on how to make this essential treatment accessible to those who need it most, visit: NerivioCovered.com —------------------------------------------------ 1. Cohen et al. "Prevalence and burden of migraine in the United States: A systematic review". 2024.

Many of our nation’s veterans face challenges long after their service ends. Did you know migraine is one of them? Migraine is more than just a common condition for veterans. It frequently occurs with other comorbidities, adding to the burden of managing post-deployment health.[1] The Nerivio? REN wearable can help with their migraine! Covered under VA benefits, this non-drug, non-disruptive, dual-use (acute and preventive) treatment offers an effective option for managing migraine, even alongside other health conditions. Learn more about VA ordering information here: https://lnkd.in/gS_fFSNJ for Nerivio —------------------------------------------------ 1. Carlson et al. "Headache Diagnoses Among Iraq and Afghanistan War Veterans Enrolled in VA: A Gender Comparison". 2013.

This #NationalCaregiversDay, we honor those who dedicate their time and energy to supporting loved ones living with migraine. At Theranica, we created the Nerivio? REN wearable not just for patients, but for caregivers too. Non-drug, non-disruptive, and easy to use, it empowers individuals with migraine to take control of their disease, offering caregivers a much-needed opportunity to focus on themselves for a change. Migraine can be especially challenging for young people, impacting their education, friendships, and daily activities.[1] Your emotional, physical, and logistical support makes a world of difference. To every caregiver: thank you for your unwavering support. You are appreciated more than words can express. —------------------------------------------------ 1. Kabbouche et al. "Management of migraine in adolescents". 2008.

Science is the bridge to innovation—and women are building it every day. This #February11 we celebrate International Day of Women and Girls in Science and recognize the incredible contributions of #WomeninSTEM and the boundless potential of the next generation. At Theranica, our mission to improve lives through non-invasive, non-drug migraine treatments would not be possible without the incredible contributions of women in science, technology, and engineering. A special recognition to Alit Stark-Inbar, PhD and Liron Rabany, PhD for their work to keep pushing boundaries and delivering transformative treatments like the Nerivio? REN wearable. Join us in recognizing the incredible women shaping the future of healthcare.

What if the key to reducing the burden of migraine in the future starts with rethinking how we treat children and adolescents today? Healthcare providers (HCPs) are on the front lines of pediatric migraine care, playing a pivotal role in identifying effective solutions and ensuring children get the treatment they need.[1] Now, with the Nerivio? REN wearable, those managing migraine have access to a transformative approach to help redefine their migraine care. As the first and only FDA-cleared, non-drug, dual-use treatment in children ages 8 and up, HCPs can offer a safe, effective, and non-disruptive option. Help potentially reduce chronification of migraine into adulthood and learn how to prescribe the REN wearable here: https://lnkd.in/gX6pb6eR —------------------------------------------------ 1. Kabbouche et al. "Management of migraine in adolescents". 2008.

Are we doing enough to provide safe and effective migraine treatments for children? A 2017 trial revealed a striking insight: Pharmacologic treatments for pediatric migraine did not significantly reduce headache frequency or disability over 24 weeks more than placebo—but they did result in higher rates of adverse events.[1] This underscores a critical need: safe, effective treatments for our younger patients. That’s where the Nerivio? REN wearable comes in—the first and only FDA-cleared, drug-free treatment for acute and preventive migraine treatment in children as young as 8. Drug-free: no systemic side effects. Empowering: enables children and adolescents to manage their migraine independently, at home, at school, or on the go.[2] Effective: backed by science and designed with young patients in mind. It’s time to rethink how we care for children with migraine. Visit https://lnkd.in/gD6-eXXe to learn more and how to prescribe. —------------------------------------------------- 1. Powers et al. “Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine”. 2016. 2. Hershey et al. “Patterns, Barriers, and Preferences of Treating Migraine Within the School Setting: A Survey Study of Students”. 2024.